leadf
logo-loader
viewSmith & Nephew PLC

Smith & Nephew posts quarterly revenue recovery

Third-quarter revenue only dipped 4% compared to a 29% decline in the previous three months

x ray

Smith & Nephew PLC (LON:SN.) said it expects third-quarter underlying revenue to decline by 4%.

The orthopaedic, sports injury and wound management group said it was a significant recovery following an overall underlying revenue decline of 29.3% for the second quarter.

READ: Smith & Nephew stumbles to loss after pandemic hits surgeries

Orthopaedics saw the strongest improvement thanks to global levels of elective surgery slowly returning to pre-pandemic figures.

Monthly group growth rates were broadly stable through the quarter, with some seasonality and monthly variation across both franchises and regions, reflecting the continuing impact of COVID-19.

"Clearly there remains a lot of uncertainty around COVID-19 and we look for further colour at the third-quarter results, particularly noting whether the Group is confident enough to issue any further guidance looking forward," analysts at Shore Capital commented.

"Any 'second wave' of the virus in the winter would likely stunt growth in elective procedures and so we expect the uncertainty to remain, particularly heading into the critical winter period in its key markets."  

Shares rose 2% to 1,549.5p early on Thursday.

--Adds analyst comment, shares--

Quick facts: Smith & Nephew PLC

Price: - -

LSE:SN
Market: LSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

HempFusion submits application to the Uk’s Food Regulatory body for product...

HempFusion (TSE: CBD- OTCQX: CBDHF) CEO Jason Mitchell joined Steve Darling from Proactive to share news the company has submitted its dossier to the United Kingdom's Regulatory Food Safety Agency. Mitchell telling Proactive the first step in the United Kingdom’s regulatory approval process...

6 hours, 20 minutes ago

2 min read